|
Neoplasia
Citations 211-220 of 4217 total displayed.
|
Past content
(since Jan 1997):
|
The effects of imatinib on pregnancy outcome
- Seonaid M. Pye, Jorge Cortes, Patricia Ault, Alan Hatfield, Hagop Kantarjian, Richard Pilot, Gianantonio Rosti, and Jane F. Apperley
Blood 2008; 111: 5505-5508.
[Abstract]
[Full text]
[PDF]
Paraffin-based 6-gene model predicts outcome in diffuse large B-cell lymphoma patients treated with R-CHOP
- Raquel Malumbres, Jun Chen, Rob Tibshirani, Nathalie A. Johnson, Laurie H. Sehn, Yaso Natkunam, Javier Briones, Ranjana Advani, Joseph M. Connors, Gerald E. Byrne, Ronald Levy, Randy D. Gascoyne, and Izidore S. Lossos
Blood 2008; 111: 5509-5514.
[Abstract]
[Full text]
[PDF]
Twenty-five–year follow-up among survivors of childhood acute lymphoblastic leukemia: a report from the Childhood Cancer Survivor Study
- Rajen Mody, Suwen Li, Douglas C. Dover, Stephen Sallan, Wendy Leisenring, Kevin C. Oeffinger, Yutaka Yasui, Leslie L. Robison, and Joseph P. Neglia
Blood 2008; 111: 5515-5523.
[Abstract]
[Full text]
[PDF]
Borrelia infection and risk of non-Hodgkin lymphoma
- Claudia Schöllkopf, Mads Melbye, Lars Munksgaard, Karin Ekström Smedby, Klaus Rostgaard, Bengt Glimelius, Ellen T. Chang, Göran Roos, Mads Hansen, Hans-Olov Adami, and Henrik Hjalgrim
Blood 2008; 111: 5524-5529.
[Abstract]
[Full text]
[PDF]
Eight-year experience with allogeneic stem cell transplantation for relapsed follicular lymphoma after nonmyeloablative conditioning with fludarabine, cyclophosphamide, and rituximab
- Issa F. Khouri, Peter McLaughlin, Rima M. Saliba, Chitra Hosing, Martin Korbling, Ming S. Lee, L. Jeffrey Medeiros, Luis Fayad, Felipe Samaniego, Amin Alousi, Paolo Anderlini, Daniel Couriel, Marcos de Lima, Sergio Giralt, Sattva S. Neelapu, Naoto T. Ueno, Barry I. Samuels, Fredrick Hagemeister, Larry W. Kwak, and Richard E. Champlin
Blood 2008; 111: 5530-5536.
[Abstract]
[Full text]
[PDF]
CD38 gene polymorphism and chronic lymphocytic leukemia: a role in transformation to Richter syndrome?
- Semra Aydin, Davide Rossi, Luciana Bergui, Giovanni D'Arena, Enza Ferrero, Lisa Bonello, Paola Omedé, Domenico Novero, Fortunato Morabito, Antonino Carbone, Gianluca Gaidano, Fabio Malavasi, and Silvia Deaglio
Blood 2008; 111: 5646-5653.
[Abstract]
[Full text]
[PDF]
Discovery of agents that eradicate leukemia stem cells using an in silico screen of public gene expression data
- Duane C. Hassane, Monica L. Guzman, Cheryl Corbett, Xiaojie Li, Ramzi Abboud, Fay Young, Jane L. Liesveld, Martin Carroll, and Craig T. Jordan
Blood 2008; 111: 5654-5662.
[Abstract]
[Full text]
[PDF]
Lestaurtinib (CEP701) is a JAK2 inhibitor that suppresses JAK2/STAT5 signaling and the proliferation of primary erythroid cells from patients with myeloproliferative disorders
- Elizabeth O. Hexner, Cynthia Serdikoff, Mahfuza Jan, Cezary R. Swider, Candy Robinson, Shi Yang, Thelma Angeles, Stephen G. Emerson, Martin Carroll, Bruce Ruggeri, and Pawel Dobrzanski
Blood 2008; 111: 5663-5671.
[Abstract]
[Full text]
[PDF]
Translocations targeting CCND2, CCND3, and MYCN do occur in t(11;14)-negative mantle cell lymphomas
- Iwona Wlodarska, Daan Dierickx, Vera Vanhentenrijk, Katrien Van Roosbroeck, Helena Pospísilová, Francesca Minnei, Gregor Verhoef, José Thomas, Peter Vandenberghe, and Chris De Wolf-Peeters
Blood 2008; 111: 5683-5690.
[Abstract]
[Full text]
[PDF]
Insight into the pathogenesis of chronic lymphocytic leukemia (CLL) through analysis of IgVH gene usage and mutation status in familial CLL
- Dalemari Crowther-Swanepoel, Ruth Wild, Gabrielle Sellick, Martin J. S. Dyer, Francesca R. Mauro, Robert J. G. Cuthbert, Viggo Jonsson, Estella Matutes, Claire Dearden, James Wiley, Stephen Fuller, Daniel Catovsky, and Richard S. Houlston
Blood 2008; 111: 5691-5693.
[Abstract]
[Full text]
[PDF]
|
|
